These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33164633)

  • 1. Impact of Diabetes Mellitus on Antithrombotic Management Patterns and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndrome: Insights From the EPICOR Asia Study.
    Guan S; Xu X; Li Y; Li J; Guan M; Wang X; Jing Q; Huo Y; Han Y
    J Am Heart Assoc; 2020 Nov; 9(22):e013476. PubMed ID: 33164633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short- and long-term follow-up of antithrombotic management patterns in patients hospitalized with acute coronary syndrome: Indian subgroup of EPICOR Asia study.
    Sawhney JPS; Mullasari A; Kahali D; Mehta V; Nair T; Kaul U; Hirematth MS
    Indian Heart J; 2019; 71(1):25-31. PubMed ID: 31000179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale, Design, and Baseline Characteristics of the EPICOR Asia Study (Long-tErm follow-uP of antithrombotic management patterns In Acute CORonary Syndrome patients in Asia).
    Huo Y; Lee SW; Sawhney JP; Kim HS; Krittayaphong R; Nhan VT; Alonso-Garcia A; Han YL; Ge J; Chin CT; Ong TK; Jan S; Itoh Y; Vega AM; Pocock S
    Clin Cardiol; 2015 Sep; 38(9):511-9. PubMed ID: 26206158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Antithrombotic Therapy and Clinical Outcomes in Patients with Acute Coronary Syndrome and Renal Impairment: Insights from EPICOR and EPICOR Asia.
    Huo Y; Van de Werf F; Han Y; Rossello X; Pocock SJ; Chin CT; Lee SW; Li Y; Jiang J; Vega AM; Medina J; Bueno H
    Am J Cardiovasc Drugs; 2021 Jul; 21(4):471-482. PubMed ID: 33537947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current patterns of antithrombotic and revascularisation therapy in patients hospitalised for acute coronary syndromes. Data from the Polish subset of the EPICOR study.
    Wojtkowska I; Stępińska J; Stępień-Wojno M; Sobota M; Kopaczewski J; Reszka Z; Kurzelewski M; Medina J
    Kardiol Pol; 2017; 75(5):445-452. PubMed ID: 28281731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry.
    Zeymer U; Annemans L; Danchin N; Pocock S; Newsome S; Van de Werf F; Medina J; Bueno H
    Eur Heart J Acute Cardiovasc Care; 2019 Mar; 8(2):121-129. PubMed ID: 29611427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic management and long-term outcomes following percutaneous coronary intervention for acute coronary syndrome in Asia.
    Zhang S; Wang W; Sawhney JPS; Krittayaphong R; Kim HS; Nhan VT; Lee SW; Ong TK; Chin CT; Pocock SJ; Huo Y; Qian J; Ge J
    Int J Cardiol; 2020 Jul; 310():16-22. PubMed ID: 32192746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term antithrombotic management patterns in Asian patients with acute coronary syndrome: 2-year observations from the EPICOR Asia study.
    Zheng B; Huo Y; Lee SW; Sawhney JPS; Kim HS; Krittayaphong R; Pocock SJ; Nhan VT; Alonso Garcia A; Chin CT; Jiang J; Jan S; Vega AM; Hayashi N; Ong TK
    Clin Cardiol; 2020 Sep; 43(9):999-1008. PubMed ID: 32618009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged dual antiplatelet therapy in patients with non-ST-segment elevation myocardial infarction: 2-year findings from EPICOR Asia.
    Zou Y; Yang S; Wang S; Lv B; Xiu L; Li L; Lee SW; Chin CT; Pocock SJ; Huo Y; Yu B
    Clin Cardiol; 2020 Apr; 43(4):346-354. PubMed ID: 31967663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet treatment in diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: a GReek AntiPlatElet registry substudy.
    Hamilos M; Petousis S; Xanthopoulou I; Goudevenos J; Kanakakis J; Sitafidis G; Vavouranakis M; Skalidis E; Kochiadakis G; Lekakis J; Vardas PE; Alexopoulos D
    Coron Artery Dis; 2018 Jan; 29(1):53-59. PubMed ID: 28834792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term antiplatelet therapy in medically managed non-ST-segment elevation acute coronary syndromes: The EPICOR Asia study.
    Zhou J; Chin CT; Huang X; Guo N; Wu Y; Yu B; Qiao S; Chen J; Han Y; Ge J; Pocock SJ; Huo Y; Wang Z; Yuan Z
    Int J Cardiol; 2021 Mar; 327():19-24. PubMed ID: 33186669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The paradox of clopidogrel use in patients with acute coronary syndromes and diabetes: insight from the Diabetes and Acute Coronary Syndrome Registry.
    Ferlini M; Musumeci G; Grieco N; Rossini R; De Servi S; Mafrici A; Sponzilli C; Demarchi A; Assanelli EM; Camisasca P; Chizzola G; Corrada E; Farina A; Pedrinazzi C; Lettieri C; Oltrona Visconti L
    Coron Artery Dis; 2018 Jun; 29(4):309-315. PubMed ID: 29309286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended dual antiplatelet therapy after acute coronary syndrome in Spain: Results from the EPICOR study.
    Bardají A; Leal M; Arrarte V; Garcia-Moll X; Pérez de Isla L; Bueno H
    Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 27885830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
    Windecker S; Lopes RD; Massaro T; Jones-Burton C; Granger CB; Aronson R; Heizer G; Goodman SG; Darius H; Jones WS; Aschermann M; Brieger D; Cura F; Engstrøm T; Fridrich V; Halvorsen S; Huber K; Kang HJ; Leiva-Pons JL; Lewis BS; Malaga G; Meneveau N; Merkely B; Milicic D; Morais J; Potpara TS; Raev D; Sabaté M; de Waha-Thiele S; Welsh RC; Xavier D; Mehran R; Alexander JH;
    Circulation; 2019 Dec; 140(23):1921-1932. PubMed ID: 31557056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel.
    Roe MT; Goodman SG; Ohman EM; Stevens SR; Hochman JS; Gottlieb S; Martinez F; Dalby AJ; Boden WE; White HD; Prabhakaran D; Winters KJ; Aylward PE; Bassand JP; McGuire DK; Ardissino D; Fox KA; Armstrong PW
    Circulation; 2013 Aug; 128(8):823-33. PubMed ID: 23852610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting two-year mortality from discharge after acute coronary syndrome: An internationally-based risk score.
    Pocock SJ; Huo Y; Van de Werf F; Newsome S; Chin CT; Vega AM; Medina J; Bueno H
    Eur Heart J Acute Cardiovasc Care; 2019 Dec; 8(8):727-737. PubMed ID: 28777005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization And Urgent Intervention Triage Strategy (ACUITY) substudy.
    Goto K; Lansky AJ; Fahy M; Cristea E; Feit F; Ohman EM; White HD; Alexander KP; Bertrand ME; Desmet W; Hamon M; Mehran R; Stone GW
    Circulation; 2010 Feb; 121(7):853-62. PubMed ID: 20142447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year outcomes post-discharge in Asian patients with acute coronary syndrome: Findings from the EPICOR Asia study.
    Huo Y; Lee SW; Sawhney JPS; Kim HS; Krittayaphong R; Pocock SJ; Nhan VT; Alonso-Garcia Á; Chin CT; Jiang J; Jan S; Vega AM; Hayashi N; Ong TK
    Int J Cardiol; 2020 Sep; 315():1-8. PubMed ID: 32389764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of antithrombotic management patterns in patients with acute coronary syndrome in Russia: an observational study (EPICOR-RUS study).
    Ruda MY; Averkov OV; Khomitskaya YV
    Curr Med Res Opin; 2017 Jul; 33(7):1269-1276. PubMed ID: 28420281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of dual antiplatelet therapy duration on 1-year clinical outcomes in diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: Insights from the real-world OPT-CAD study.
    Li J; Li Y; Qiu M; Li Z; Yang J; Wang X; Bao D; Wang X; Han Y
    Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():579-586. PubMed ID: 31872515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.